Status:
UNKNOWN
Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer
Lead Sponsor:
Wolfson Medical Center
Conditions:
ART
Eligibility:
FEMALE
18-39 years
Phase:
NA
Brief Summary
The current trial is intended to assess the efficacy of oral versus vaginal progesterone for luteal support in frozen IVF cycles.
Detailed Description
Progesteron is used for luteal phase support in IVF cycles. Progesterone can be administered vaginally and orally. Duphaston is an oral progesterone drug, which has recentlly been proven effective in ...
Eligibility Criteria
Inclusion
- Ages 18-39
- Modified natural cycle (induction of ovulation with HCG)
- Consent to participation
Exclusion
- None
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03832699
Start Date
March 1 2019
End Date
October 1 2021
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edith Wolfson Medical Center
Holon, Israel, 5822012